Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanomedicine to fight infectious disease

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.113996Source: DataRank Database

Nanomedicine to fight infectious disease is a research paper published in Advanced Drug Delivery Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.52)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jacob S. Brenner ORCID,Kathryn M. Rubey ORCID

Live enrichment

PubMed:34634395 PMC:PMC8665093 OpenAlex:https://openalex.org/W3205000420

NHLBI NIH HHS

Grant: R01 HL153510

NHLBI NIH HHS

Grant: K08 HL138269

NHLBI NIH HHS

Grant: F32 HL151026

National Institutes of Health

FWCI

2.52

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8665093

publisherhttps://api.elsevier.com/content/article/PII:S0169409X21003896?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X21003896?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.addr.2021.113996

Fields of Study

Bacterial biofilms and quorum sensingAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceAnti-Bacterial AgentsAntiviral AgentsBacterial InfectionsBiofilmsChronic DiseaseDrug CarriersDrug Evaluation, PreclinicalDrug Resistance, Multiple, BacterialHumansInflammation MediatorsMicrobiotaNanoparticle Drug Delivery SystemVirus Diseases

MeSH Terms

Nanoparticle Drug Delivery SystemAnti-Bacterial AgentsAntiviral AgentsBacterial InfectionsChronic DiseaseDrug CarriersDrug Evaluation, PreclinicalHumansVirus DiseasesBiofilmsInflammation MediatorsDrug Resistance, Multiple, BacterialMicrobiota

Keywords

AntibioticsNanomedicineMedicineIntensive care medicineInfectious disease (medical specialty)DiseaseMicrobiomeDrugImmunologyBiologyBioinformaticsMicrobiologyPharmacologyNanotechnologyPathologyBiofilmNanoparticleChronic infectionBacterial resistanceHost Inflammatory Response

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure

Nanomedicine to fight infectious disease

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)